SAN FRANCISCO--(BUSINESS WIRE)--Bridge Pharmaceuticals announced today the appointment of James Carignan, B.S. RQAP-GLP as Vice President of Quality Assurance and Regulatory Compliance for its Beijing P.R.C. operations. Mr. Carignan comes to Bridge as a nationally recognized expert in Good Laboratory Practices (GLPs) with 25 years of experience in toxicology and analytical laboratories for multi-national corporations and CRO’s. Prior to joining Bridge, Mr. Carignan was responsible for directing the quality assurance program at Novartis (formerly Chiron Corporation at Emeryville, CA). He is an expert in writing and implementing SOPs to support a GLP program, developing and conducting GLP training for all levels of senior staff, scientists, and general staff, and directing internal and external GLP site inspections. Mr. Carignan also previously held the position of Director of Quality Assurance and Regulatory Affairs at TherImmune Research where he was responsible for complete oversight of the QAU including maintaining the Master Schedule, Provantis data collection system validation processes, and preparation/submission of INDs.
